Red blood cell fatty acid profile of chronic renal failure patients receiving maintenance haemodialysis treatment

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 67, Issue 1, 2002, Pages 13-18

  Koorts, A M ^a   Viljoen, M ^a   Kruger, M C ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ESSENTIAL FATTY ACID; ICOSANOID; OMEGA 6 FATTY ACID;

ADOLESCENT; ADULT; ARTICLE; CHRONIC INFLAMMATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID ANALYSIS; FEMALE; GENETIC INCOMPATIBILITY; HEMODIALYSIS; HUMAN; ICOSANOID METABOLISM; IMMUNOSTIMULATION; MALE; PRIORITY JOURNAL; PROCESS MONITORING;

EID: 0036661280     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.2002.0375     Document Type: Article

References (16)

1. Sardesai V. M. The essential fatty acids. Nutr Clin Prac 1992; 7: 179-186.
2. Peck L. W., Monsen E. R., Ahmad S. Effect of three sources of long-chain fatty acids on the plasma fatty acid profile, plasma prostaglandin E2 concentrations, and pruritus symptoms in HD patients. Am J Clin Nutr 1996; 64: 210-214.
3. Ahmad S., Dasgupta A., Kenny M. A. Fatty acid abnormalities in hemodialysis patients: effect of L-carnitine administration. Kidney Int 1989; 36(Suppl 27): S243-S246.
4. Kalofoutis A., Nicolaidou-Politis V., Bouloukos A. Significance of lymphocyte fatty acid changes in chronic renal failure. Nephron 1996; 73: 704-706.
5. Ramsay B., Cream J. J., Curtis J. R., Manku M. S., Stewart J. C. M. Erythrocyte membrane docosahexanoic acid in haemodialysis patients on erythropoetin. The Lancet 1992; 339: 1232-1233.
6. Christensen J. H., Aaroe J., Knudsen N., Dideriksen K., Kornerup H. J., Dyerberg J. Heart rate variability and n-3 fatty acids in patients with chronic renal failure - a pilot study. Clin Nephrol 1998; 49(2): 102-106.
7. Dasgupta A., Kenny M. A., Ahmad S. Abnormal fatty acid profile in chronic hemodialysis patients: possible deficiency of essential fatty acids, Clin Physiol Biochem 1990; 8: 238-243.
8. Peck L. W. Essential fatty acid deficiency in renal failure. Can supplements really help? J Am Dietary Assoc 1997; 97(10 Suppl 2): S150-S153.
9. Ylikorkala O., Huttunen K., Järvi J., Viinikka L. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis. Clin Nephrol 1982; 18(2): 83-87.
10. Folch J., Lees M., Sloane-Stanley G. H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
11. Taccone-Gallucci M., Lubrano R., Clerico A., Meloni C., Morosetti M., Meschini L. Administration of GSH has no influence on the RBC membrane: oxidative damage to patients on hemodialysis. ASAIO J 1992; 38: 855-857.
12. Duncan C. J. Calcium, Oxygen Radicals and Cellular Damage. Cambridge, UK: Cambridge University Press, 1991.
13. Hornych A., Remy P, Luong N., Aumont J., Bariety J. Biocompatibility of haemodialysis membranes: heamodialysis-related Leukotriene B4 and C4 generation. Nephron 1996; 74: 11-18.
14. Foidart J. B., Davin J.-C., Malaise M., Saint-Remy M., Mahieu P. Stimulation of platelet lipoxygenase during hemodialysis. Kidney Int 1988; 33(Suppl 24): S80-S81.
15. Viljoen M., de Oliveira A. A., Milne F. J. Physical properties of the red blood cells in chronic renal failure. Nephron 1991; 59: 271-278.
16. Schultze G., Heitz J., Krais T. H., Neumayer H.-H., Wagner K., Molzahn M. The impact of eicosanoids on compliance, cardiovascular performance, and coagulation during hemodialysis. Biomed Biochim Acta 1984; 43(8/9): S426-S429.